North America Endothelial Dysfunction Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Endothelial Dysfunction Market – by Cause

1.3.2 North America Endothelial Dysfunction Market – by Test Type

1.3.3 North America Endothelial Dysfunction Market – by End User

1.3.4 North America Endothelial Dysfunction Market – by Country

2. North America Endothelial Dysfunction Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Endothelial Dysfunction Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.3 Expert Opinion

5. North America Endothelial Dysfunction Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidences of Cardiovascular Diseases

5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity

5.2 Market Restraints

5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction

5.3 Market Opportunities

5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies

5.4 Future Trends

5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction

5.5 Impact Analysis

6. Endothelial Dysfunction Market – North America Analysis

6.1 North America Endothelial Dysfunction Market Revenue Forecast and Analysis

7. North America Endothelial Dysfunction Market Analysis – by Cause

7.1 Overview

7.2 North America Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)

7.3 Hypertension

7.3.1 Overview

7.3.2 Hypertension: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

7.4 Diabetes

7.4.1 Overview

7.4.2 Diabetes: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

7.5 Hypercholestrolaemia

7.5.1 Overview

7.5.2 Hypercholestrolaemia: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

7.6 Behcet’s Disease

7.6.1 Overview

7.6.2 Behcet’s Disease: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

7.7 Obesity

7.7.1 Overview

7.7.2 Obesity: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. North America Endothelial Dysfunction Market Analysis – by Test Type

8.1 Overview

8.2 North America Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)

8.3 Invasive Tests

8.3.1 Overview

8.3.2 Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4 Non-Invasive Tests

8.4.1 Overview

8.4.2 Non-Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4.3 Flow Mediated Dilatory

8.4.3.1 Overview

8.4.3.2 Flow Mediated Dilatory: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4.4 Venous Occlusion Plethysmography

8.4.4.1 Overview

8.4.4.2 Venous Occlusion Plethysmography: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4.5 Peripheral Arterial Tonometry (PAT)

8.4.5.1 Overview

8.4.5.2 Peripheral Arterial Tonometry (PAT): North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4.6 Circulating Markers

8.4.6.1 Overview

8.4.6.2 Circulating Markers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8.4.7 Others

8.4.7.1 Overview

8.4.7.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. North America Endothelial Dysfunction Market Analysis – by End User

9.1 Overview

9.2 North America Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostics Centers

9.4.1 Overview

9.4.2 Diagnostics Centers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9.5 Clinics

9.5.1 Overview

9.5.2 Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. North America Endothelial Dysfunction Market – Revenue and Forecast to 2028 – Country Analysis

10.1 North America: Endothelial Dysfunction Market

10.1.1 Overview

10.1.1.1 US: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 US: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 US: Endothelial Dysfunction Market, by Cause, 2020–2028 (US$ Million)

10.1.1.1.4 US: Endothelial Dysfunction Market, by Test Type – 2020–2028 (US$ Million)

10.1.1.1.4.1 US: Endothelial Dysfunction Market, by Non-Invasive Tests – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.5 US: Endothelial Dysfunction Market, by End User 2020–2028 (US$ Million)

10.1.1.2 Canada: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Canada: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Canada: Endothelial Dysfunction Market, by Cause, 2020–2028 (US$ Million)

10.1.1.2.4 Canada: Endothelial Dysfunction Market, by Test Type – 2020–2028 (US$ Million)

10.1.1.2.4.1 Canada: Endothelial Dysfunction Market, by Non-Invasive Tests – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.5 Canada: Endothelial Dysfunction Market, by End User 2020–2028 (US$ Million)

10.1.1.3 Mexico: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 Mexico: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 Mexico: Endothelial Dysfunction Market, by Cause, 2020–2028 (US$ Million)

10.1.1.3.4 Mexico: Endothelial Dysfunction Market, by Test Type – 2020–2028 (US$ Million)

10.1.1.3.4.1 Mexico: Endothelial Dysfunction Market, by Non-Invasive Tests – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5 Mexico: Endothelial Dysfunction Market, by End User 2020–2028 (US$ Million)

11. North America Endothelial Dysfunction Market–Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Endothelial Dysfunction Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 ZOLL Medical Corp

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Lawrence Berkeley National Laboratory

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Endothelix Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Perimed AB

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6

12.4.7 Key Developments

12.5 SMART Medical Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Everist Health Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Medizinische Messtechnik GmbH

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Techniques Used in to Assess Endothelial Function

Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases

Table 3. US Endothelial Dysfunction Market, by Cause – Revenue and Forecast to 2028 (US$ Million)

Table 4. US Endothelial Dysfunction Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. US Endothelial Dysfunction Market, by Non-Invasive Tests – Revenue and Forecast to 2028 (US$ Million)

Table 6. US Endothelial Dysfunction Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada Endothelial Dysfunction Market, by Cause – Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada Endothelial Dysfunction Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada Endothelial Dysfunction Market, by Non-Invasive Tests – Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada Endothelial Dysfunction Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11. Mexico Endothelial Dysfunction Market, by Cause – Revenue and Forecast to 2028 (US$ Million)

Table 12. Mexico Endothelial Dysfunction Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 13. Mexico Endothelial Dysfunction Market, by Non-Invasive Tests – Revenue and Forecast to 2028 (US$ Million)

Table 14. Mexico Endothelial Dysfunction Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 15. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market

Table 16. Recent Organic Growth Strategies in the Endothelial Dysfunction Market

Table 17. Glossary of Terms, Endothelial dysfunction market

LIST OF FIGURES

Figure 1. North America Endothelial Dysfunction Market Segmentation

Figure 2. North America Endothelial Dysfunction Market, by Country

Figure 3. North America Endothelial Dysfunction Market Overview

Figure 4. Hypertension Account for Largest Share of Cause Segment in North America Endothelial Dysfunction Market

Figure 5. The US Expected to Show Remarkable Growth During Forecast Period

Figure 6. North America: PEST Analysis

Figure 7. Expert Opinion

Figure 8. North America Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints

Figure 9. North America Endothelial Dysfunction Market – Revenue Forecast and Analysis – 2020–2028

Figure 10. North America Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)

Figure 11. Hypertension: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. Diabetes: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Hypercholestrolaemia: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Behcet’s disease: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 15. Obesity: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 17. North America Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)

Figure 18. Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 19. Non-Invasive Tests: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 20. Flow Mediated Dilatory: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 21. Venous Occlusion Plethysmography: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 22. Peripheral Arterial Tonometry (PAT): North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 23. Circulating Markers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 24. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. North America Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)

Figure 26. Hospitals and Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. Diagnostics Centers: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. Clinics: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Others: North America Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Figure 30. North America: Endothelial Dysfunction Market, by Key Country – Revenue (2022) (US$ Million)

Figure 31. North America: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)

Figure 32. US: Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Canada: Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Mexico: Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Growth Strategies in the Endothelial Dysfunction Market